• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Dec29
Distribution Plan(EST)

Cash dividend 1.6838 USD

Dec22
Distribution Plan(EST)

Cash dividend 1.6838 USD

Distribution Plan(EST)

Cash dividend 1.6838 USD

View More

Event Tracking

Dec22
VistaGen Therapeutics Nasal Fasedienol Phase 3 Trial for Social Anxiety Fails to Meet Primary Endpoint
22:29
Neuroseer Biologics' Valbenazine Phase 3 Clinical Trial for Cerebral Palsy Fails to Meet Endpoints
21:06
Dec11
Atai Beckley NV Obtains New US Patent for Oral R-MDMA Until 2043
12:01
Dec9
Neurosecretion Biopharma to Host 2025 R&D Day on December 16
21:01
Dec6
TD Cowen Raises Neurocrine Biosciences Target Price to $200
17:56
Dec3
Russell Investments Reduces Holdings in Neurosign Bioscience
10:51